Research programme - targeted protein degrader therapeutics - Almirall/Univesity of Dundee
Alternative Names: PROCTACs - Almirall/University of Dundee; PROTAC therapeutics - Almirall/University of DundeeLatest Information Update: 28 Oct 2020
At a glance
- Originator Almirall S.A.; University of Dundee
- Class Skin disorder therapies; Small molecules
- Mechanism of Action Proteolysis
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Skin disorders
Most Recent Events
- 08 Oct 2020 Almirall and the University of Dundee agree to co-develop PROTACs therapeutics for Skin disorders
- 08 Oct 2020 Early research in Skin disorders in Spain (unspecified route) before October 2020
- 08 Oct 2020 Early research in Skin disorders in United Kingdom (unspecified route) before October 2020